tiprankstipranks
Trending News
More News >
Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD
US Market
Advertisement

Galmed Pharmaceuticals (GLMD) Income Statement

Compare
1,295 Followers

Galmed Pharmaceuticals Income Statement

Last quarter (Q4 2024), Galmed Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Galmed Pharmaceuticals's net income was $-3.21M. See Galmed Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -83.00K$ -31.00K$ -35.00K$ -42.00K$ -39.00K
Operating Expenses
$ -6.28M$ -7.49M$ 17.65M$ 32.88M$ 30.21M
Depreciation and Amortization
$ 83.00K$ 31.00K$ 35.00K$ 42.00K$ 39.00K
EBITDA
$ -7.42M$ -6.87M$ -17.62M$ -32.84M$ -30.17M
Operating Income
$ -6.28M$ 7.49M$ -17.65M$ -32.88M$ -30.21M
Other Income/Expenses
$ -1.24M$ -14.40M$ -215.00K$ 414.00K$ 1.44M
Pretax Income
$ -7.52M$ -6.91M$ -17.87M$ -32.47M$ -28.77M
Net Income
$ -7.52M$ -6.91M$ -18.57M$ -31.95M$ -27.61M
Per Share Metrics
Basic EPS
$ -8.08$ -30.05$ -11.08$ -19.48$ -19.46
Diluted EPS
$ -8.08$ -29.95$ -11.08$ -19.48$ -19.46
Weighted Average Shares Outstanding
930.82K 230.00K 1.68M 1.64M 1.42M
Weighted Average Shares Outstanding (Diluted)
930.82K 230.79K 1.68M 1.64M 1.42M
Currency in USD

Galmed Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis